Loading clinical trials...
Loading clinical trials...
The North Star study is a multi-center, Phase 2, double-blind, randomized, parallel group clinical study to evaluate the safe and effective dose conversion from Levothyroxine to North Star therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neuvosyn Laboratories, LLC
NCT00001159 · Hyperthyroidism, Hypothyroidism, and more
NCT07408765 · Hypothyroidism Primary
NCT07380854 · Subclinical Hypothyroidism
NCT07323706 · Hypothyroidism Primary
NCT06083636 · Hypothyroidism
Neuvosyn Investigational Site
Birmingham, Alabama
Neuvosyn Investigational Site
Canoga Park, California
Neuvosyn Investigational Site
Greenbrae, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions